{"schema_version":"secwatch.filing_event.v1","accession":"0001708599-26-000060","form_type":"8-K","ticker":"SER","cik":"0001708599","company_name":"Serina Therapeutics, Inc.","filed_at":"2026-10-09T21:19:26+00:00","discovered_at":"2026-10-09T21:20:00.285216+00:00","generated_at":"2026-10-12T14:58:00.881855+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Serina Therapeutics eliminates Series A Preferred stock designation after all shares convert to common","bullets":["Certificate of Elimination filed with Delaware Secretary of State on October 5, 2026, removing all Series A Convertible Preferred terms from the charter.","Series A Certificate of Designations originally filed April 10, 2025, and corrected May 22, 2025; no Series A Preferred shares remain outstanding.","All issued Series A Preferred converted into common stock, and none will be issued; eliminated shares revert to authorized but unissued undesignated preferred stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001708599-26-000060","json":"https://secwatch.observer/filing/0001708599-26-000060.json","markdown":"https://secwatch.observer/filing/0001708599-26-000060.md","text":"https://secwatch.observer/filing/0001708599-26-000060.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708599/000170859926000060/0001708599-26-000060-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708599/000170859926000060/ser-20261005.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T14:58:00.881855+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}